Incidence and risk factors for recurrent membranous nephropathy after kidney transplantation: a systematic review and

Jiang Bai1, Zhifang Zheng2, Jiajing Cao1

  • 1Second Clinical Medical College, Shanxi Medical University, Taiyuan, Shanxi, China.

Annals of Medicine
|June 27, 2025
PubMed
Abstract

Insights

Recurrent membranous nephropathy (MN) after kidney transplant is common. Living donors, high anti-PLA2R antibody levels, and shorter dialysis increase risk, while certain immunosuppressants offer protection.

Area of Science:

  • Nephrology
  • Transplantation Immunology
  • Clinical Epidemiology

Background:

  • Membranous nephropathy (MN) recurrence post-kidney transplant presents diagnostic challenges due to unclear risk factors.
  • Identifying predictive clinical features is crucial for managing recurrent MN.

Purpose of the Study:

  • To systematically review and analyze risk factors associated with recurrent MN after kidney transplantation.
  • To provide evidence-based insights for clinical decision-making in transplant recipients.

Main Methods:

  • A systematic review and meta-analysis of case-control studies published up to March 2023.
  • Searched multiple databases (PubMed, Embase, Web of Science, etc.) for relevant studies.
  • Statistical analysis performed using Stata 12.0, protocol registered on PROSPERO.

Main Results:

  • The incidence of recurrent MN was 34%, with higher detection rates via surveillance biopsies.
  • Risk factors included living donors, pre-transplant anti-phospholipase A2 receptor autoantibody (anti-PLA2R) levels, and shorter dialysis duration.
  • Induction immunosuppression and tacrolimus use were identified as protective factors.

Conclusions:

  • Recurrent MN remains a significant concern post-transplantation.
  • Clinical evaluation should prioritize living donor selection, pre-transplant anti-PLA2R levels, dialysis duration, and immunosuppressive strategies.

Related Concept Videos

Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
85
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
78
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
33
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
65
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
101
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
97